Results 1 to 10 of about 744 (148)

Atypical chronic myeloid leukemia: From diagnosis to molecular features and therapeutic options [PDF]

open access: yesHemaSphere
Atypical chronic myeloid leukemia (aCML) is a rare form of myelodysplastic (MDS)/myeloproliferative neoplasm (MPN) overlap disorder characterized by neutrophilic leukocytosis with circulating immature myeloid cells (IMC), frequent hepatosplenomegaly, and
Alessandra Iurlo   +3 more
doaj   +3 more sources

EE-ACML: Energy-Efficient Adiabatic CMOS/MTJ Logic for CPA-Resistant IoT Devices [PDF]

open access: yesSensors, 2021
Internet of Things (IoT) devices have strict energy constraints as they often operate on a battery supply. The cryptographic operations within IoT devices consume substantial energy and are vulnerable to a class of hardware attacks known as side-channel ...
Himanshu Thapliyal, Zachary Kahleifeh
exaly   +6 more sources

Comprehensive Analysis of Atypical Chronic Myeloid Leukemia (aCML): Epidemiology, Clinical Features, and Survival Outcomes Based on SEER Database Insights [PDF]

open access: yesLeukemia Research Reports
Background: Atypical Chronic Myeloid Leukemia (aCML) is a rare and aggressive myelodysplastic syndrome/myeloproliferative neoplasm. This study aimed to provide a comprehensive understanding of the epidemiology, clinical characteristics, and survival ...
Fan Wang
exaly   +4 more sources

Avapritinib treatment of KIT D816V-mutant atypical chronic myeloid leukemia [PDF]

open access: yesLeukemia Research Reports, 2023
Background: Atypical chronic myeloid leukemia (aCML) is a rare myelodysplastic/myeloproliferative neoplasm. There is no proven standard of care treatment and the only curative option available is hematopoietic stem cell transplant.
Lyndsey Sandow, Michael Heinrich
doaj   +2 more sources

Atypical chronic myeloid leukemia found in a patient with eosinophilia for six years: a case report [PDF]

open access: yesBMC Geriatrics
Background Atypical chronic myeloid leukemia (aCML) is a highly aggressive type of blood cancer that falls under the category of myelodysplastic/myeloproliferative neoplasms (MDS/MPN).
Moqin Jiang   +5 more
doaj   +2 more sources

Adaptive EEG preprocessing to mitigate electrode shift variability for robust motor imagery classification [PDF]

open access: yesScientific Reports
Electrode placement variability poses a critical challenge in EEG-based motor imagery tasks, often resulting in reduced classification robustness. We present the Adaptive Channel Mixing Layer (ACML), a plug-and-play preprocessing module that dynamically ...
Wenjing Xiong, Lin Ma, Haifeng Li
doaj   +2 more sources

A case report of atypical chronic myeloid leukemia with complete hematological and major molecular response to Venetoclax/Azacitidine treatment [PDF]

open access: yesFrontiers in Oncology
Atypical Chronic Myeloid Leukemia (aCML), a myeloproliferative neoplasm with poor prognosis, was reclassified as aCML by the ICC classification, and as MDS/MPN with neutrophilia by the WHO 2022 classification.
Hongxia Chen   +6 more
doaj   +2 more sources

Case report: Safety and efficacy of synergistic treatment using selinexor and azacitidine in patients with atypical chronic myeloid leukemia with resistance to decitabine [PDF]

open access: yesFrontiers in Oncology
BackgroundAtypical chronic myeloid leukemia (aCML) is a BCR::ABL1 negative myelodysplastic/myeloproliferative neoplasm with poor overall survival.
Lu Liu   +4 more
doaj   +2 more sources

Resistance to imatinib in a ETV6::PDGFRB rearranged myeloid/lymphoid neoplasm with high-risk mutations: a case report [PDF]

open access: yesFrontiers in Oncology
Platelet-derived growth factor receptor beta (PDGFRB)-rearranged myeloid/lymphoid neoplasms (MLNs) are rare hematologic malignancies typically responsive to tyrosine kinase inhibitors (TKIs) such as imatinib.
Lucia Cavelier   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy